Catenulipeptin
| Internal ID | f322dfec-f840-4218-bba9-d8060851ccc3 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (2S)-2-[[(2S)-2-[[(3S,9S,11R,14S,17S,20R)-9-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[(3S,9S,11R,14S,17S,23R)-9-[[(2S)-2-[[2-[[2-[[2-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-17-[(1R)-1-hydroxyethyl]-3-(2-methylpropyl)-2,5,8,12,15,18,21-heptaoxo-14-propan-2-yl-25-thia-1,4,7,13,16,19,22-heptazaspiro[10.15]hexacosane-23-carbonyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-[(2S)-butan-2-yl]-14,17-bis(2-methylpropyl)-2,5,8,12,15,18-hexaoxo-22-thia-1,4,7,13,16,19-hexazaspiro[10.12]tricosane-20-carbonyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C99H152N32O34S2/c1-14-48(12)78-94(161)131-98(39-167-38-64(90(157)121-59(23-76(145)146)88(155)122-60(95(162)163)18-46(8)9)125-84(151)52(15-43(2)3)119-85(152)53(16-44(4)5)126-96(98)164)24-61(83(150)110-36-74(142)127-78)123-86(153)56(20-51-28-103-42-113-51)116-72(140)33-108-81(148)57(21-65(101)133)120-89(156)63-37-166-40-99(97(165)129-77(47(10)11)93(160)128-79(49(13)132)92(159)111-35-73(141)118-63)25-62(82(149)109-34-71(139)115-54(17-45(6)7)91(158)130-99)124-87(154)58(22-75(143)144)117-70(138)32-106-68(136)30-104-67(135)29-105-69(137)31-107-80(147)55(114-66(134)26-100)19-50-27-102-41-112-50/h27-28,41-49,52-64,77-79,132H,14-26,29-40,100H2,1-13H3,(H2,101,133)(H,102,112)(H,103,113)(H,104,135)(H,105,137)(H,106,136)(H,107,147)(H,108,148)(H,109,149)(H,110,150)(H,111,159)(H,114,134)(H,115,139)(H,116,140)(H,117,138)(H,118,141)(H,119,152)(H,120,156)(H,121,157)(H,122,155)(H,123,153)(H,124,154)(H,125,151)(H,126,164)(H,127,142)(H,128,160)(H,129,165)(H,130,158)(H,131,161)(H,143,144)(H,145,146)(H,162,163)/t48-,49+,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,77-,78-,79-,98-,99-/m0/s1 |
| InChI Key | AXDPBAOMGSGZMT-PMTSSQHDSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C99H152N32O34S2 |
| Molecular Weight | 2398.60 g/mol |
| Exact Mass | 2398.0623672 g/mol |
| Topological Polar Surface Area (TPSA) | 1070.00 Ų |
| XlogP | -10.90 |
| Atomic LogP (AlogP) | -15.25 |
| H-Bond Acceptor | 36 |
| H-Bond Donor | 34 |
| Rotatable Bonds | 49 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8386 | 83.86% |
| Caco-2 | - | 0.8581 | 85.81% |
| Blood Brain Barrier | - | 0.9000 | 90.00% |
| Human oral bioavailability | - | 0.6286 | 62.86% |
| Subcellular localzation | Lysosomes | 0.4992 | 49.92% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.7955 | 79.55% |
| OATP1B3 inhibitior | + | 0.9363 | 93.63% |
| MATE1 inhibitior | - | 0.8409 | 84.09% |
| OCT2 inhibitior | - | 1.0000 | 100.00% |
| BSEP inhibitior | + | 0.9692 | 96.92% |
| P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
| P-glycoprotein substrate | + | 0.8684 | 86.84% |
| CYP3A4 substrate | + | 0.7529 | 75.29% |
| CYP2C9 substrate | - | 0.5987 | 59.87% |
| CYP2D6 substrate | - | 0.8412 | 84.12% |
| CYP3A4 inhibition | - | 0.9506 | 95.06% |
| CYP2C9 inhibition | - | 0.8518 | 85.18% |
| CYP2C19 inhibition | - | 0.8053 | 80.53% |
| CYP2D6 inhibition | - | 0.8985 | 89.85% |
| CYP1A2 inhibition | - | 0.8645 | 86.45% |
| CYP2C8 inhibition | + | 0.8527 | 85.27% |
| CYP inhibitory promiscuity | - | 0.9420 | 94.20% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.7700 | 77.00% |
| Carcinogenicity (trinary) | Non-required | 0.5747 | 57.47% |
| Eye corrosion | - | 0.9853 | 98.53% |
| Eye irritation | - | 0.8952 | 89.52% |
| Skin irritation | - | 0.7699 | 76.99% |
| Skin corrosion | - | 0.9242 | 92.42% |
| Ames mutagenesis | - | 0.6191 | 61.91% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7142 | 71.42% |
| Micronuclear | + | 0.7800 | 78.00% |
| Hepatotoxicity | + | 0.5125 | 51.25% |
| skin sensitisation | - | 0.8420 | 84.20% |
| Respiratory toxicity | + | 0.8000 | 80.00% |
| Reproductive toxicity | + | 0.8929 | 89.29% |
| Mitochondrial toxicity | + | 0.7875 | 78.75% |
| Nephrotoxicity | - | 0.8423 | 84.23% |
| Acute Oral Toxicity (c) | III | 0.5461 | 54.61% |
| Estrogen receptor binding | - | 0.6102 | 61.02% |
| Androgen receptor binding | + | 0.7715 | 77.15% |
| Thyroid receptor binding | + | 0.8153 | 81.53% |
| Glucocorticoid receptor binding | + | 0.8476 | 84.76% |
| Aromatase binding | + | 0.8270 | 82.70% |
| PPAR gamma | + | 0.7775 | 77.75% |
| Honey bee toxicity | - | 0.6209 | 62.09% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.5300 | 53.00% |
| Fish aquatic toxicity | + | 0.7280 | 72.80% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.87% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.86% | 96.09% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 99.78% | 90.17% |
| CHEMBL236 | P41143 | Delta opioid receptor | 99.58% | 99.35% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.43% | 97.23% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 99.18% | 93.10% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 99.04% | 88.42% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 98.54% | 94.55% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 98.48% | 98.05% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 98.30% | 85.14% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 97.86% | 97.64% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 97.85% | 90.20% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.74% | 97.09% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.94% | 94.66% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.71% | 91.11% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 95.47% | 94.75% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 95.22% | 89.34% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 94.86% | 92.50% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 94.66% | 97.14% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 94.36% | 96.11% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 93.97% | 96.90% |
| CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 93.75% | 99.09% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 93.42% | 98.59% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 93.28% | 90.08% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 93.08% | 92.29% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 92.07% | 95.50% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 91.52% | 90.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 91.51% | 93.56% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 91.27% | 95.93% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 91.22% | 83.10% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 91.18% | 89.33% |
| CHEMBL4662 | P28074 | Proteasome Macropain subunit MB1 | 90.70% | 93.85% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 90.47% | 89.63% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 90.40% | 98.94% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 90.33% | 94.45% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 90.32% | 100.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 90.03% | 93.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 89.55% | 90.71% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 89.04% | 95.00% |
| CHEMBL3837 | P07711 | Cathepsin L | 89.00% | 96.61% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 88.69% | 99.17% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 88.53% | 98.33% |
| CHEMBL202 | P00374 | Dihydrofolate reductase | 88.17% | 89.92% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 88.13% | 90.24% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 87.97% | 88.56% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 87.86% | 96.00% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 87.83% | 94.00% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 87.34% | 94.00% |
| CHEMBL2243 | O00519 | Anandamide amidohydrolase | 87.24% | 97.53% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 86.94% | 82.38% |
| CHEMBL4801 | P29466 | Caspase-1 | 86.34% | 96.85% |
| CHEMBL6175 | Q9H3R0 | Lysine-specific demethylase 4C | 86.25% | 96.69% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 86.00% | 95.71% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 85.83% | 99.15% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 85.72% | 89.50% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 85.24% | 97.33% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 85.17% | 93.03% |
| CHEMBL1628481 | P35414 | Apelin receptor | 85.11% | 97.89% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 84.83% | 97.21% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 84.25% | 100.00% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 84.23% | 95.27% |
| CHEMBL1801 | P00747 | Plasminogen | 84.03% | 92.44% |
| CHEMBL1981 | P06213 | Insulin receptor | 83.61% | 97.37% |
| CHEMBL2821 | P00748 | Coagulation factor XII | 83.49% | 96.21% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 83.39% | 95.38% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 83.31% | 99.23% |
| CHEMBL1966 | Q02127 | Dihydroorotate dehydrogenase | 83.20% | 96.09% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 82.99% | 89.00% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 82.03% | 95.50% |
| CHEMBL2850 | P49840 | Glycogen synthase kinase-3 alpha | 81.53% | 88.84% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 81.11% | 85.11% |
| CHEMBL2535 | P11166 | Glucose transporter | 81.08% | 98.75% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 80.75% | 100.00% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 80.64% | 92.80% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 80.60% | 96.33% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 80.33% | 97.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139585188 |
| LOTUS | LTS0138880 |
| wikiData | Q77385481 |